Advertisement

Update 1988 pp 286-292 | Cite as

Pre-hospital Thrombolytic Intervention in the Treatment of Acute Myocardial Infarction

  • L. L. Bossaert
Part of the Update in Intensive Care and Emergency Medicine book series (UICM, volume 5)

Abstract

In an attempt to limit infarct size, the objective of treatment of acute myocardial infarction (AMI) has changed in the past 20 years from limitation of myocardial oxygen consumption (nitrates, beta-blockers, vasodilators) towards improvement of tissue oxygen availability by dissolving the occluding thrombus in the infarctrelated coronary artery. Well-designed controlled studies have proven the value of thrombolytic treatment, especially when initiation occurs very early [1–6].

Keywords

Acute Myocardial Infarction Acute Myocardial Infarction Thrombolytic Treatment Anisoylated Plasminogen Streptokinase Activator Complex Thrombolytic Drug 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kennedy J, Ritchie J, Davis, et al (1985) The Western Washington randomized trial of intracoronary streptokinase in Acute Myocardial Infarction. N Engl J Med 312:1073–1078.PubMedCrossRefGoogle Scholar
  2. 2.
    TIMI Study group (1984) The thrombolysis in myocardial infarction trial. N Eng J Med 310:609–613.CrossRefGoogle Scholar
  3. 3.
    Verstraete M, Bernard R, Bory M, et al (1985) Randomized trial of IV rt-PA versus IV streptokinase in acute myocardial infarction. Lancet i:842–847.CrossRefGoogle Scholar
  4. 4.
    Simoons M, Serruys P, Brand M vd, et al (1985) Improved survival after early thrombolysis in acute myocardial infarction. Lancet ii:578–582.CrossRefGoogle Scholar
  5. 5.
    GISSI (1986) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet i:397–402.Google Scholar
  6. 6.
    ISIS steering committee (1987) Intravenous streptokinase given within 0–4 hours of onset of myocardial infarction reduced mortality in ISIS-2. Lancet i:502.CrossRefGoogle Scholar
  7. 7.
    Koren G, Weiss AT, Hasin Y, et al (1985) Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. N Engl J Med 313:1384–1389.PubMedCrossRefGoogle Scholar
  8. 8.
    Fine DG, Weiss AT, Sapoznikov D, et al (1986) Importance of early initiation of intravenous Streptokinase therapy for acute myocardial infarction. Am J Cardiol 58:411–417.PubMedCrossRefGoogle Scholar
  9. 9.
    The ISAM Study Group (1986) A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM). N Engl J Med 314:1465–1471.CrossRefGoogle Scholar
  10. 10.
    Sainsous J, Serradimigni A, Richard JL, Guize L, Leconte T, Tanielian P (1985) How many patients with acute myocardial infarction could be treated in France by intravenous streptokinase? Results of a prospective trial (ENIM 1984). Eur Heart J Suppl 1, 67; (abstract) 197.Google Scholar
  11. 11.
    Hartmann JR, McKeever LM, Bufalino VB, et al (1986) Intravenous streptokinase in acute myocardial infarction: experience of community hospitals served by paramedics. Am Heart J 111:1030–1034.PubMedCrossRefGoogle Scholar
  12. 12.
    EMIP subcommittee (1987) Potential time saving with pre-hospital intervention in acute myocardial infarction (submitted).Google Scholar
  13. 13.
    Weiss AT, Fine DG, Appelbaum D, et al (1987) Prehospital coronary thrombolysis. A new strategy in acute myocardial infarction. Chest 92:124–128.PubMedCrossRefGoogle Scholar
  14. 14.
    Villemant D, Barriot P, Bodenan P (1987) Thrombolysis in acute myocardial infarction. A race against time. In: JL Vincent (ed) Update in Intensive Care and Emergency Medicine, vol 3. Springer, Berlin Heidelberg New York London Paris Tokyo, pp 277–286.Google Scholar
  15. 15.
    Castaigne AD, Duval AM, Dubois-Rande JL, et al (1987) Prehospital administration of APSAC in acute myocardial infarction. Drugs 33:231–234.PubMedCrossRefGoogle Scholar
  16. 16.
    Editorial (1987) Thrombolytic therapy for acute myocardial infarction. Lancet ii:138-140.Google Scholar
  17. 17.
    Bippus PH, Haux R, Schroder R (1987) Prehospital intravenous streptokinase in evolving myocardial infarction: a randomized study about feasibility, safety and time gain. Eur Heart Journal 8, 103.Google Scholar
  18. 18.
    Bossaert L, Belgian EMS study group (1987) Safety and tolerance data from the Belgian multicenter study of APSAC versus heparine in acute myocardial infarction. Drugs 33:287–292.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • L. L. Bossaert

There are no affiliations available

Personalised recommendations